T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Southern Copper
SCCO
$165B
| $518M | 0.06% |
3,722,257
-250,823
| -6% | -$32.8M |
|
252
Consolidated Edison
ED
$39.9B
| $517M | 0.06% |
5,200,840
+514,178
| +11% | +$51M |
|
253
Franco-Nevada
FNV
$45.5B
| $514M | 0.06% |
2,477,975
-268,508
| -10% | -$54.5M |
|
254
RTX Corp
RTX
$300B
| $513M | 0.06% |
2,798,472
+23,923
| +0.9% | +$4.16M |
|
255
Penumbra
PEN
$12.9B
| $511M | 0.06% |
1,644,094
-150,173
| -8% | -$41.5M |
|
256
Encompass Health
EHC
$12.3B
| $510M | 0.06% |
4,805,413
+948,202
| +25% | +$110M |
|
257
Samsara
IOT
$22.9B
| $509M | 0.05% |
14,370,027
-2,821,243
| -16% | -$109M |
|
258
Rocket Companies
RKT
$39.8B
| $507M | 0.05% |
26,189,869
+25,966,725
| +11,637% | +$464M |
|
259
Cintas
CTAS
$81.4B
| $505M | 0.05% |
2,683,582
+112,622
| +4% | +$21.2M |
|
260
Wingstop
WING
$3.05B
| $503M | 0.05% |
2,111,089
+58,386
| +3% | +$14.5M |
|
261
Pultegroup
PHM
$24.6B
| $502M | 0.05% |
4,284,197
+2,392,580
| +126% | +$293M |
|
262
Voya Financial
VOYA
$9.01B
| $502M | 0.05% |
6,735,202
-18,856
| -0.3% | -$1.37M |
|
263
Cummins
CMI
$87.8B
| $500M | 0.05% |
980,252
-635,715
| -39% | -$297M |
|
264
Diamondback Energy
FANG
$56.2B
| $496M | 0.05% |
3,302,432
-140,262
| -4% | -$20.7M |
|
265
TKO Group
TKO
$14.3B
| $496M | 0.05% |
2,373,243
+395,040
| +20% | +$76.8M |
|
266
Rambus
RMBS
$11B
| $495M | 0.05% |
5,385,570
+140,226
| +3% | +$13.8M |
|
267
Cooper Companies
COO
$15B
| $494M | 0.05% |
6,028,821
+2,231,568
| +59% | +$167M |
|
268
Digital Realty Trust
DLR
$72.9B
| $494M | 0.05% |
3,190,797
+1,405,791
| +79% | +$231M |
|
269
Targa Resources
TRGP
$57.6B
| $493M | 0.05% |
2,674,422
-890
| -0% | -$150K |
|
|
NVO
270
Novo Nordisk
NVO
$203B
| $493M | 0.05% |
9,688,262
+4,836,285
| +100% | +$247M |
|
271
Steel Dynamics
STLD
$37.7B
| $489M | 0.05% |
2,884,669
-439,621
| -13% | -$69.8M |
|
272
Planet Fitness
PLNT
$3.65B
| $488M | 0.05% |
4,503,409
-629,886
| -12% | -$64.8M |
|
273
Trane Technologies
TT
$105B
| $483M | 0.05% |
1,242,031
+45,978
| +4% | +$19M |
|
274
Honeywell
HON
$74.6B
| $481M | 0.05% |
2,468,031
-503,286
| -17% | -$98.4M |
|
275
Kymera Therapeutics
KYMR
$9.48B
| $479M | 0.05% |
6,159,335
+1,061,957
| +21% | +$71.7M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.